Project Grant K23MH141306
- Federal Grant Award Summary The University of South Carolina received a K23 Career Development Award of $163,534 from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), effective September 4, 2025 through August 31, 2029. This award supports the development of an implementation scientist focused on increasing equitable access to autism-specialized supports within the Part C Early Intervention (EI) system. The project addresses gaps in...
- Federal Grant Award Summary Emory University received a $713,195 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) for an Implementation Pilot Elopement project, awarded August 1, 2025, with completion scheduled for July 31, 2028. The project addresses a significant research-to-practice gap in evidence-based treatment for elopement—a dangerous behavior prevalent among children with autism spectrum disorder (ASD). Emory...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of California, Davis a Project Grant totaling $383,832 on September 10, 2025, under the Mental Health Research Grants program (CFDA 93.242) to support research extending through August 31, 2029. The project delivers a research intervention program called Family/Friend Network Support for Early Intervention (FANS-EI), designed to improve caregiver engagement in community-based autism early...
- Federal Grant Award Summary Emory University received a $628,380 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on May 13, 2026, with completion targeted for February 28, 2031. The project, "Dopaminergic and Noradrenergic Mechanisms of Emotion-Related Memory Over Development," will deliver research services investigating how emotional experiences drive selective memory prioritization across...
- Federal Grant Award Summary Emory University received a $156,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded September 1, 2025, with completion targeted for August 31, 2027. The project conducts secondary data analysis of an existing randomized clinical trial to optimize safety toolkits for elopement—a dangerous and prevalent behavior among individuals...
- Federal Project Grant Award Summary Emory University received a $156,500 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) effective September 1, 2025, through August 31, 2027. The research project, "Investigating the Neuronal Function of ZNF185," delivers scientific investigation into the role of zinc-finger protein 185 (ZNF185) in synaptic function and neural development. The research employs a recently...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Boston Children's Hospital a $990,550 Project Grant (CFDA 93.242: Mental Health Research Grants) effective March 10, 2026, through February 29, 2028, to develop and test a cognitive control training intervention for school-aged children with autism spectrum disorder (ASD). The grant supports an R61/R33 phased research initiative designed to determine whether computer-based cognitive control and metacognition...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Virginia a Project Grant of $160,579 (K23 mentored research award) beginning September 1, 2025, and concluding August 31, 2029, under the Mental Health Research Grants program (CFDA 93.242). This funding supports the adaptation and implementation of SAFETY-A (Safe Alternatives for Teens and Youths-Acute), a cognitive behavioral therapy-informed intervention originally designed for emergency...
- Summary of Federal Grant Award The National Institute of Mental Health (NIMH) awarded a Project Grant of $175,017 to the University of Houston System on September 15, 2025, under the Mental Health Research Grants program (CFDA 93.242). The award supports a five-year research initiative (through August 31, 2030) investigating neural predictors of real-world social attention in autism during naturalistic social interactions. The project addresses a critical gap in autism research by moving...
- Federal Grant Award Summary Emory University received a $234,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 11, 2026, with a completion date of April 30, 2028. The research project investigates NMDA (N-methyl-D-aspartate) receptor regulation of rapid synaptic scaling and spinal excitability in Fragile X Syndrome, a...
Emory University received a $196,990 K23 Career Development Award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective May 1, 2026, through April 30, 2030. This award supports the development of an independent investigator with expertise in implementation science through a structured program combining mentored research, coursework, workshops, and seminars. The primary deliverables include enhanced investigator capacity in three critical areas: human-centered design and community-engaged research methods for improving intervention acceptability; expertise in designing and conducting pragmatic, hybrid clinical trials that measure both effectiveness and implementation outcomes; and competency in evaluating implementation strategies at the system level. The research aims focus on adapting and testing the ECHO Autism: STAT Early Diagnosis (EDX) implementation strategy to improve early access to evidence-based autism services in pediatric primary care settings. Specific products include: an adapted implementation strategy utilizing a biomarker-based diagnostic tool for patients 16-30 months old; a pilot cluster randomized hybrid Type 3 trial examining feasibility and acceptability of technology-enhanced approaches; and comparative analysis of time-to-diagnosis outcomes across pediatric primary care sites. These outcomes will generate evidence regarding system-level implementation effectiveness and contribute to the broader goal of increasing uptake and utilization of evidence-based autism services in primary care.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $197.0k | 5/7/26 |